Table 3.
Density | Normal | High | P-value | |||||
---|---|---|---|---|---|---|---|---|
Methionine | 100% | 130% | 100% | 130% | SEM | Density | MET | Interaction |
ALT, U/L | ||||||||
Grower | 0.82 | 0.76 | 0.75 | 0.72 | 0.08 | 0.55 | 0.60 | 0.88 |
Finisher | 0.92 | 1.04 | 0.86 | 1.03 | 0.11 | 0.78 | 0.24 | 0.82 |
AKP, U/mL | ||||||||
Grower | 284b | 287b | 251b | 455a | 31.8 | 0.05 | <0.01 | <0.01 |
Finisher | 324 | 370 | 314 | 328 | 23.0 | 0.29 | 0.22 | 0.51 |
PIP, mg/dL | ||||||||
Grower | 68.3 | 70.6 | 69.2 | 67.3 | 1.24 | 0.34 | 0.87 | 0.09 |
Finisher | 55.8 | 56.6 | 55.9 | 53.9 | 2.12 | 0.54 | 0.78 | 0.54 |
Glucose, g/L | ||||||||
Grower | 2.94ab | 2.81b | 3.11a | 2.73b | 0.08 | 0.57 | <0.01 | 0.14 |
Finisher | 2.55 | 2.75 | 2.68 | 2.66 | 0.12 | 0.88 | 0.49 | 0.36 |
Uric acid, mmol/L | ||||||||
Grower | 281 | 291 | 288 | 289 | 15.8 | 0.89 | 0.75 | 0.79 |
Finisher | 238b | 287a | 267ab | 298a | 13.1 | 0.17 | <0.01 | 0.51 |
TC, mg/dL | ||||||||
Grower | 78.9b | 89.4a | 86.1ab | 90.6a | 2.46 | 0.12 | <0.01 | 0.25 |
Finisher | 75.6 | 71.8 | 74.4 | 74.7 | 2.14 | 0.69 | 0.42 | 0.33 |
TG, mg/dL | ||||||||
Grower | 40.9a | 31.7b | 44.4a | 40.6a | 2.29 | 0.02 | 0.01 | 0.28 |
Finisher | 35.0ab | 40.0a | 32.3b | 37.7ab | 2.00 | 0.23 | 0.02 | 0.93 |
NEFA, μmol/L | ||||||||
Grower | 0.15 | 0.15 | 0.17 | 0.16 | 0.01 | 0.18 | 0.74 | 0.69 |
Finisher | 0.13 | 0.13 | 0.12 | 0.11 | <0.01 | 0.09 | 0.64 | 0.29 |
1Data are expressed as means (n = 10). The main effects (the stocking density and concentration of supplemental dl-methionine) were analyzed by two-way ANOVA and Duncan’s multiple range test was used to compare the treatment means. Means in the same row without a common letter differ significantly (P < 0.05).